Evogene Ltd. (EVGN) is an Israeli biotechnology company that uses computational biology and advanced breeding technologies to develop new seed traits and microorganisms for a range of agricultural and industrial applications. The company was founded in 2002 and has its headquarters in Rehovot, Israel.
Evogene's platform integrates various genomic, computational, and biological tools to identify, test, and develop new traits and products for crops and other industries. The company's technology aims to improve the yield and quality of crops, while also addressing challenges related to climate change, food security, and sustainability.
Evogene has several subsidiaries, including Biomica Ltd., which is focused on developing microbiome-based therapies for various diseases. The company has collaborations and partnerships with several leading companies in the agriculture, food, and healthcare sectors, including Bayer, Corteva Agriscience, and ICL Group.
Evogene is listed on the NASDAQ Global Market under the ticker symbol "EVGN."
|
